Skip to search formSkip to main contentSkip to account menu

RPR 130737

Known as: 4-hydroxy-3-(2-oxo-3-(5-pyridin-3-ylthiophene-2-ylsulfonylamino)pyrrolidin-1-ylmethyl)benzamide trifluoroacetate, RPR-130737, RPR130737 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

AmidinesFactor Xa inhibitorsSulfones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
In vitro characterization of a novel factor Xa inhibitor, RPR 130737.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)